Therapeutic approaches to reduce airway inflammation.
Hoffmann-La Roche Inc., Nutley, NJ 07110.
M
M
O'Donnell
A N
AN
Payne
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001792:Blood Platelets / Q000502:physiology; D001980:Bronchi / Q000187:drug effects; D015815:Cell Adhesion Molecules / Q000502:physiology; D006801:Humans; D006918:Hydroxyurea / Q000031:analogs & derivatives / Q000627:therapeutic use; D018799:Intercellular Adhesion Molecule-1; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D015815:Cell Adhesion Molecules; D015848:Interleukin-5; D016859:Lipoxygenase Inhibitors; D018799:Intercellular Adhesion Molecule-1; C063449:zileuton; D006918:Hydroxyurea